Literature DB >> 12427783

Effect of Pentavac and measles-mumps-rubella (MMR) vaccination on the intestine.

B Thjodleifsson1, K Davídsdóttir, U Agnarsson, G Sigthórsson, M Kjeld, I Bjarnason.   

Abstract

BACKGROUND: The safety of infant vaccination has been questioned in recent years. In particular it has been suggested that the measles, mumps, and rubella (MMR) vaccination leads to brain damage manifesting as autism consequent to the development of an "enterocolitis" in the immediate post-vaccination period. AIM: To assess if MMR vaccination is associated with subclinical intestinal inflammation, which is central to the autistic "enterocolitis" theory.
METHODS: We studied 109/58 infants, before and two and four weeks after immunisation with Pentavac and MMR vaccines, for the presence of intestinal inflammation (faecal calprotectin).
RESULTS: Neither vaccination was associated with any significant increase in faecal calprotectin concentrations.
CONCLUSIONS: The failure of the MMR vaccination to cause an intestinal inflammatory response provides evidence against the proposed gut-brain interaction that is central to the autistic "enterocolitis" hypothesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12427783      PMCID: PMC1773472          DOI: 10.1136/gut.51.6.816

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  28 in total

Review 1.  Detection of persistent measles virus infection in Crohn's disease: current status of experimental work.

Authors:  S Ghosh; E Armitage; D Wilson; P D Minor; M A Afzal
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

2.  Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease.

Authors:  S K Bunn; W M Bisset; M J Main; B E Golden
Journal:  J Pediatr Gastroenterol Nutr       Date:  2001-02       Impact factor: 2.839

3.  Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism.

Authors:  R I Furlano; A Anthony; R Day; A Brown; L McGarvey; M A Thomson; S E Davies; M Berelowitz; A Forbes; A J Wakefield; J A Walker-Smith; S H Murch
Journal:  J Pediatr       Date:  2001-03       Impact factor: 4.406

4.  A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method.

Authors:  B Johne; O Kronborg; H I Tøn; J Kristinsson; P Fuglerud
Journal:  Scand J Gastroenterol       Date:  2001-03       Impact factor: 2.423

5.  Gastrointestinal abnormalities in children with autistic disorder.

Authors:  K Horvath; J C Papadimitriou; A Rabsztyn; C Drachenberg; J T Tildon
Journal:  J Pediatr       Date:  1999-11       Impact factor: 4.406

6.  Paramyxovirus infections in childhood and subsequent inflammatory bowel disease.

Authors:  S M Montgomery; D L Morris; R E Pounder; A J Wakefield
Journal:  Gastroenterology       Date:  1999-04       Impact factor: 22.682

7.  A simple method for assessing intestinal inflammation in Crohn's disease.

Authors:  J Tibble; K Teahon; B Thjodleifsson; A Roseth; G Sigthorsson; S Bridger; R Foster; R Sherwood; M Fagerhol; I Bjarnason
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

8.  Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease.

Authors:  J A Tibble; G Sigthorsson; S Bridger; M K Fagerhol; I Bjarnason
Journal:  Gastroenterology       Date:  2000-07       Impact factor: 22.682

9.  Enterocolitis in children with developmental disorders.

Authors:  A J Wakefield; A Anthony; S H Murch; M Thomson; S M Montgomery; S Davies; J J O'Leary; M Berelowitz; J A Walker-Smith
Journal:  Am J Gastroenterol       Date:  2000-09       Impact factor: 10.864

Review 10.  An assessment of thimerosal use in childhood vaccines.

Authors:  L K Ball; R Ball; R D Pratt
Journal:  Pediatrics       Date:  2001-05       Impact factor: 7.124

View more
  4 in total

Review 1.  Developmental biology of the enteric nervous system: pathogenesis of Hirschsprung's disease and other congenital dysmotilities.

Authors:  Michael D Gershon; Elyanne M Ratcliffe
Journal:  Semin Pediatr Surg       Date:  2004-11       Impact factor: 2.754

2.  MMR: marginalised, misrepresented and rejected? Autism: a focus group study.

Authors:  Shona Hilton; Kate Hunt; Mark Petticrew
Journal:  Arch Dis Child       Date:  2007-04       Impact factor: 3.791

3.  Association of clinical characteristics and lifestyle factors with fecal S100/calgranulin concentrations in healthy dogs.

Authors:  Romy M Heilmann; Melissa M Guard; Linda Toresson; Stefan Unterer; Aurélien Grellet; Niels Grützner; Jan S Suchodolski; Joerg M Steiner
Journal:  Vet Med Sci       Date:  2021-03-10

4.  Parents' champions vs. vested interests: who do parents believe about MMR? A qualitative study.

Authors:  Shona Hilton; Mark Petticrew; Kate Hunt
Journal:  BMC Public Health       Date:  2007-03-28       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.